nipah
viru
niv
first
recogn
zoonot
diseas
outbreak
associ
highli
lethal
febril
enceph
human
predominantli
respiratori
diseas
pig
period
deadli
outbreak
document
persontoperson
transmiss
potenti
viru
agent
agroterror
reinforc
need
effect
mean
therapi
prevent
report
describ
vaccin
potenti
niv
viruslik
particl
niv
vlp
compos
three
niv
protein
g
f
coexpress
protein
optim
condit
result
quantifi
amount
vlp
mani
viruslikevaccin
desir
properti
includ
previous
describ
vlp
paramyxoviru
particl
fusogen
induc
syncytia
format
pcr
array
analysi
show
niv
vlpinduc
activ
innat
immun
defens
pathway
surfac
structur
niv
vlp
imag
cryoelectron
microscopi
dens
order
repetit
consist
similarli
deriv
structur
paramyxoviru
measl
viru
vlp
compos
three
viral
protein
design
intracellular
process
also
appear
similar
niv
virion
size
morpholog
surfac
composit
vlp
consist
parent
viru
importantli
retain
antigen
potenti
final
particl
formul
without
adjuv
abl
induc
neutral
antibodi
respons
balbc
mice
find
indic
vaccin
potenti
particl
basi
undertak
futur
protect
efficaci
studi
anim
model
niv
diseas
sinc
first
recogn
nipah
viru
niv
caus
sever
outbreak
human
encephalit
diseas
associ
high
lethal
first
outbreak
malaysia
singapor
human
becam
sick
die
epidemiolog
link
point
human
contact
sick
pig
commerci
piggeri
outbreak
brought
control
cull
approxim
million
pig
sinc
viru
reemerg
bangladesh
neighbor
india
start
caus
sever
smaller
even
deadlier
diseas
outbreak
case
fatal
rate
rang
unlik
malaysian
outbreak
rout
transmiss
outbreak
consid
battohuman
via
food
contamin
bat
saliva
case
nosocomi
transmiss
persontoperson
spread
also
note
addit
concern
niv
also
potenti
agent
agroterror
sinc
rate
transmiss
viru
pig
popul
close
effect
vaccin
therapi
need
combat
threat
pose
niv
niv
member
genu
henipaviru
subfamili
paramyxovirina
famili
paramyxovirida
sever
distinct
genet
biolog
featur
although
morpholog
genom
organ
similar
member
subfamili
niv
six
gene
arrang
tandem
p
f
g
n
p
l
requir
reconstitut
viral
rna
polymeras
activ
matrix
protein
requir
particl
format
bud
two
surfac
glycoprotein
g
f
requir
attach
entri
host
cell
identifi
niv
entri
receptor
fusion
viru
cell
membran
viral
ribonucleoprotein
releas
cell
cytoplasm
follow
transcript
replic
viral
compon
migrat
plasma
membran
assembl
bud
progeni
particl
two
vaccin
strategi
niv
diseas
prevent
alreadi
explor
experiment
canarypox
virusbas
vaccin
vector
approach
effect
veterinari
vaccin
process
develop
approach
human
use
vaccin
undergo
extens
evalu
larg
hiv
aid
solubl
niv
g
protein
approach
also
shown
promis
howev
subunit
approach
gener
less
effect
particul
immunogen
suffer
suboptim
present
immun
system
immunogen
mice
niv
glycoprotein
report
recent
use
two
vector
approach
gene
deliveri
one
use
venezuelan
equin
enceph
viru
replicon
involv
inocul
mix
two
complement
defect
vesicular
stomat
viru
vsvdg
vector
one
express
two
niv
glycoprotein
latter
approach
new
seem
promis
regulatori
approv
human
vaccin
might
problemat
studi
explor
potenti
niv
viruslik
particl
vlp
vaccin
plasmidmedi
express
select
viral
protein
result
spontan
assembl
releas
vlp
particl
make
highli
effect
immunogen
possess
sever
featur
authent
viru
surfac
structur
dimens
also
safe
contain
viral
genet
materi
vlp
one
constitu
protein
serv
immunogen
nativ
vlp
particularli
effect
vaccin
infecti
diseas
fact
two
vaccin
gardasil
merck
co
human
papillomaviru
hpv
scibvac
scigen
biohepb
glaxosimthklin
hepat
b
viru
hbv
alreadi
approv
human
use
mani
nonenvelop
envelop
virus
variou
stage
develop
attest
desir
approach
vaccin
develop
bud
capac
viru
protein
vlp
proteinprotein
interact
facilit
process
central
role
protein
vlp
assembl
releas
describ
sever
paramyxovirus
sendai
viru
sev
newcastl
diseas
viru
ndv
respiratori
syncyti
viru
rsv
paramyxoviru
simian
viru
human
parainfluenza
viru
type
effici
vlp
format
virtual
studi
base
protein
releas
supernat
niv
viruslik
particl
also
describ
result
studi
show
niv
g
f
protein
individu
retain
bud
capac
although
far
less
effici
protein
niv
n
f
gcontain
vlp
resembl
viru
respect
differ
significantli
respect
ratio
vlpincorpor
f
protein
present
precursor
f
form
recent
vaccin
potenti
nativ
vlp
ndv
describ
particl
compos
hn
f
np
protein
sever
viruslik
properti
howev
sinc
f
protein
formul
modifi
design
ablat
cleavag
site
remain
precursor
form
consequ
ndv
vlp
nonfusogen
therefor
incap
induc
syncytia
format
describ
niv
vlp
compos
two
surfac
glycoprotein
g
f
matrix
protein
g
f
protein
includ
mediat
attach
entri
host
cell
major
target
neutral
antibodi
major
player
vaccin
induc
protect
niv
g
f
togeth
also
effect
immunogen
elucid
canari
pox
viru
vectorbas
experiment
protect
efficaci
studi
protein
includ
formul
requir
particl
format
releas
optim
condit
abl
make
substanti
quantifi
amount
niv
vlp
compos
three
niv
protein
allow
us
character
properti
detail
show
possess
mani
viruslikevaccin
desir
properti
vitro
also
allow
us
test
immunogen
vivo
balbc
mice
note
although
niv
caus
diseas
anim
niv
protein
inject
known
induc
robust
neutral
antibodi
respons
importantli
nivspecif
mous
monoclon
antibodi
protect
hamster
model
niv
diseas
studi
care
assess
immunogen
shown
first
time
niv
vlp
abl
induc
neutral
antibodi
respons
also
provid
detail
methodolog
optim
product
vlp
research
purpos
beyond
provid
first
cryoem
studi
niv
vlp
thu
provid
care
assess
morpholog
demonstr
niv
vlp
trigger
fusion
without
upon
addit
cell
knowledg
first
envelop
vlp
final
shown
niv
vlp
activ
innat
immun
signal
infect
cell
provid
transcript
profil
respons
base
attribut
niv
f
gproteincontain
vlp
show
promis
vaccin
basi
undertak
futur
protect
efficaci
studi
anim
model
niv
diseas
niv
express
plasmid
pcaggsg
f
control
chicken
beta
actin
promot
construct
laboratori
one
coauthor
studi
cb
describ
previous
human
embryon
kidney
cell
atcc
cell
atcc
grown
dulbecco
minimum
essenti
medium
supplement
fetal
bovin
serum
fb
penicillin
streptomycin
maintain
medium
contain
fb
minigenom
use
optim
vlp
format
describ
previous
initi
minigenomebas
optim
step
done
cell
gift
dr
n
ito
condit
applic
produc
vlp
cell
use
throughout
gener
vlp
use
work
describ
studi
cell
grown
dulbecco
complet
medium
achiev
semiconflu
densiti
cell
monolay
cell
transient
transfect
plasmid
construct
use
lipid
reagent
lipofectamin
accord
gener
guidelin
provid
manufactur
instruct
invitrogen
inc
hr
posttransfect
vlpcontain
cell
supernat
sup
harvest
concentr
purif
vlp
fusogen
properti
vlp
widespread
syncytia
format
time
point
although
cell
still
adher
vlp
releas
transfectedcel
sup
harvest
clarifi
centrifug
rpm
minut
concentr
sucros
densiti
gradient
centrifug
base
previou
descript
briefli
clarifi
sup
concentr
ultracentrifug
sucros
cushion
tn
buffer
nacl
trishcl
ph
g
hour
result
vlp
pellet
ml
volum
purifi
discontinu
sucros
gradient
form
layer
sucros
tn
buffer
centrifug
g
hour
top
ml
gradient
includ
vlpcontain
band
interfac
sucros
layer
resuspend
sucros
buffer
centrifug
g
one
hour
result
pellet
resuspend
sucros
solut
endotoxinfre
tn
bufffer
store
subsequ
analysi
supernat
cell
transfect
empti
pcagg
plasmid
process
similarli
refer
mock
particl
serv
neg
control
need
sinc
ratio
protein
express
plasmid
use
transfect
time
harvest
may
bear
level
vlp
format
minigenomebas
vlp
infect
assay
similar
describ
previous
use
determin
rel
concentr
constitu
plasmid
determin
kinet
vlp
format
optim
product
assay
provid
compar
assess
vlp
format
sinc
account
vlp
abl
incorpor
passag
minigenom
howev
base
assumpt
ratio
empti
minigenomecontain
vlp
equival
reaction
method
provid
indirect
mean
determin
optim
set
condit
vlp
product
determin
vlpincorpor
minigenomeencod
cat
enzym
activ
briefli
step
involv
vlp
infect
assay
transfect
niv
minigenom
construct
cotransfect
full
complement
niv
protein
express
plasmid
n
p
l
f
g
use
lipofectamin
follow
replic
hour
posttransfect
passag
equal
volum
vlpcontain
transfect
cell
sup
fresh
cell
previous
transfect
n
p
l
plasmid
determin
cat
activ
vlp
infect
cell
hour
later
replic
vlpincorpor
incom
mingenom
base
report
gene
activ
indic
level
particl
format
releas
vlp
infect
success
minigenom
packag
fast
cat
assay
kit
molecular
probe
use
accord
manufactur
instruct
allow
accur
quantif
cat
enzym
level
wide
linear
rang
vlp
purifi
describ
particl
adsorb
formvar
carbon
coat
copper
grid
float
drop
vlp
suspens
minut
grid
blot
neg
stain
aqueou
uranyl
acet
view
transmiss
electron
microscopi
vlp
vitrifi
report
previous
holey
carbon
film
grid
cflat
tm
protochip
raleigh
north
carolina
vlp
imag
indic
magnif
use
slowscan
ccd
camera
ultrascan
gatan
inc
pleasanton
ca
use
lowdos
imag
procedur
unfix
vlp
use
immunogold
label
limit
antibodi
reactiv
cell
surfac
protein
particl
adsorb
formvar
coat
nickel
grid
stain
niv
specif
primari
antibodi
hyper
immun
mous
ascit
fluid
hmaf
obtain
dr
p
rollin
cdc
dilut
buffer
bsa
tri
buffer
rins
wash
buffer
bsa
tri
buffer
stain
colloid
gold
label
goat
antimous
secondari
antibodi
jackson
immunoresearch
laboratori
wash
neg
stain
uranyl
acet
view
em
total
protein
concentr
purifi
vlp
prepar
measur
bca
bicinchonin
acid
method
thermo
scientif
laboratori
vlp
composit
determin
western
blot
analysi
briefli
purifi
vlp
resuspend
endotoxin
free
pb
lyse
resuspend
equal
amount
sd
proteinload
buffer
load
sdspolyacrylamid
gel
stack
gel
cell
lysat
process
similarli
run
parallel
neg
cell
control
follow
electrophoresi
resolv
protein
band
transfer
membran
blot
incub
nivspecif
hmaf
primari
antibodi
dilut
dilut
overnight
hrpconjug
antimous
secondari
antibodi
ge
healthcar
dilut
one
hour
room
temperatur
protein
reveal
use
western
blot
detect
reagent
accord
instruct
provid
manufactur
ge
healthcar
studi
undertaken
approv
institut
biosafeti
committe
protocol
institut
anim
care
use
iacuc
committe
protocol
five
six
week
old
femal
balbc
mice
harlan
laboratori
hous
microisolat
cage
day
anim
resourc
center
univers
texa
medic
branch
begin
immun
protocol
mice
group
five
immun
subcutan
inocul
four
differ
concentr
vlp
mg
mous
refer
subsequ
treatment
group
respect
prepar
prior
use
steril
endotoxin
free
pb
adjuv
use
group
five
mice
inocul
steril
endotoxin
free
pb
serv
neg
control
group
mice
four
treatment
group
boost
mg
mous
day
neg
control
group
receiv
pb
blood
collect
submandibular
vein
anim
day
euthan
day
plaqu
reduct
neutral
test
prnt
twofold
dilut
test
sera
made
ml
cell
cultur
medium
biohazard
level
condit
dilut
sera
mix
ml
niv
dilut
gener
plaqu
form
unit
incub
min
preincub
virusantibodi
mix
ad
vero
cell
monolay
grown
well
plate
incub
min
inoculum
remov
replac
ml
cell
media
incub
h
cell
fix
icecold
methanol
stain
indirect
immunofluoresc
assay
follow
well
plate
block
bsapb
stain
rabbit
sera
rais
g
protein
hev
goat
antirabbit
alexa
fluor
conjug
invitrogen
dilut
block
buffer
viral
plaqu
visual
count
neutral
antibodi
titer
report
base
reduct
plaqu
count
rel
untreat
control
prnt
antibodi
level
measur
immunofluoresc
assay
ifa
ifa
nivspecif
total
antibodi
level
measur
use
niv
g
f
express
cell
target
antigen
thirti
six
hour
posttransfect
cell
harvest
fix
paraformaldehyd
cytospun
cytocentrifug
thermoscientif
glass
slide
obtain
monolay
prepar
store
use
antigen
within
three
week
prepar
day
use
slide
wash
pb
permeabil
block
bsapb
incub
two
fold
dilut
test
sera
cell
monolay
wash
stain
alexa
fluor
goat
antimous
antibodi
accord
manufactur
molecular
probe
instruct
neg
posit
control
run
parallel
batch
gene
express
profil
realtim
pcr
vlpmediat
transcript
activ
test
eighti
four
gene
involv
tolllik
receptor
tlr
mediat
signal
transduct
use
rt
profil
pcr
array
sabiosci
well
array
format
includ
mediat
tlr
signal
includ
adaptor
protein
interact
tlr
member
nfkb
irf
signal
pathway
downstream
tlr
signal
briefli
cell
grown
overnight
mm
dish
expos
mg
purifi
vlp
suspend
ml
optimem
invitrogen
mock
particl
see
method
vlp
harvest
purif
resuspend
similarli
expos
cell
serv
neg
control
inoculum
adsorb
cell
monolay
hour
addit
ml
optimem
ad
dish
incub
twenti
four
post
vlp
exposur
total
cell
rna
extract
accord
manufactur
sabiosci
instruct
integr
rna
verifi
agaros
gel
electrophoresi
concentr
total
cell
rna
vlpstimul
mock
stimul
cell
use
gene
express
profil
realtim
pcr
use
eppendorf
mastercycl
unit
array
plate
includ
posit
neg
control
qualiti
assur
three
set
housekeep
gene
normal
data
analysi
foldchang
gene
express
vlp
stimul
cell
rel
mock
stimul
cell
calcul
ddct
method
accord
manufactur
instruct
preliminari
studi
found
coexpress
niv
g
f
protein
cell
result
format
vlp
bud
transfect
cell
sup
harvest
concentr
purifi
describ
method
howev
vlp
yield
low
improv
effici
vlp
format
proceed
optim
ratio
three
express
plasmid
use
transfect
specul
would
import
base
fact
replic
paramyxovirus
form
transcript
gradient
proxim
gene
transcrib
abundantli
success
downstream
gene
b
stoichiometri
interact
viral
protein
prove
critic
plasmiddriven
minigenom
fulllength
rescu
system
import
protein
ratio
vlp
format
allud
previou
ndv
studi
express
plasmid
cotransfect
predetermin
concentr
produc
vlpincorpor
protein
ratio
analog
viru
infect
cell
studi
patch
el
al
equival
amount
niv
n
f
g
initi
use
produc
vlp
studi
vlp
subsequ
also
made
adjust
niv
express
plasmid
concentr
experiment
variat
similarli
ndv
studi
effici
particl
format
bud
mani
paramyxoviru
vlp
format
system
base
protein
releas
chosen
minigenomebas
function
assay
vlp
infect
assay
describ
materi
method
determin
optim
express
plasmid
ratio
effici
vlp
format
base
report
gene
readout
briefli
cell
transfect
plasmid
shown
figur
titrat
niv
g
f
plasmid
increas
concentr
either
g
f
express
plasmid
turn
cotransfect
fix
concentr
two
plasmid
minigenom
n
p
l
plasmid
transfect
use
predetermin
ratio
vlpcontain
cell
sup
harvest
hour
posttransfect
clarifi
centrifug
equal
volum
passag
onto
fresh
cell
monolay
vlpinfect
cell
previous
transfect
core
protein
requir
support
incom
packag
minigenom
vlp
infect
cell
harvest
hour
later
test
optim
particl
product
base
incom
minigenomeencod
cat
activ
time
point
chosen
maxim
vlp
format
also
found
time
depend
optim
hour
postpassag
data
shown
reproduc
result
verifi
independ
repeat
experi
result
present
figur
show
within
given
rang
base
level
minigenomeencod
cat
activ
vari
concentr
g
f
plasmid
bear
vlp
format
cat
activ
vlp
infect
cell
appear
optim
box
lane
analysi
ensur
report
activ
linear
rang
data
shown
indic
largest
amount
minigenomecontain
niv
vlp
produc
cell
transfect
niv
f
g
plasmid
ratio
lane
ratio
use
make
vlp
prepar
optim
condit
appli
transfect
g
f
express
plasmid
cell
grown
cm
dish
vlpcontain
cultur
sup
harvest
hour
later
concentr
purifi
describ
briefli
clarifi
sup
concentr
ultracentrifug
sucros
cushion
purifi
discontinu
sucros
gradient
vlp
pellet
resuspend
tn
buffer
view
em
neg
stain
result
present
figur
show
vlpcontain
band
sucros
gradient
view
neg
stain
purifi
particl
transmiss
electron
microscopi
figur
show
numer
viruslik
particl
size
variat
vlp
consist
parent
viru
niv
pleomorph
viru
rang
size
nm
size
vlp
rang
nm
particl
also
resembl
authent
niv
morpholog
seen
clearli
magnifi
imag
present
figur
fring
glycoprotein
clearli
visibl
vlp
surfac
occasion
vlp
appear
doubl
fring
shown
arrow
featur
frequent
associ
hendra
rather
niv
viru
particl
imag
figur
cryoelectron
micrograph
one
vlp
overal
surfac
appear
viruslik
describ
dens
order
repetit
show
surfac
glycoprotein
spatial
arrang
even
definit
verifi
whether
niv
protein
incorpor
vlp
design
purifi
particl
analyz
western
blot
use
nivspecif
mous
antibodi
hrpconjug
antimous
secondari
antibodi
describ
method
right
hand
panel
figur
show
vlpincorpor
protein
two
differ
prepar
niv
vlp
protein
band
consist
size
niv
protein
g
f
f
protein
rel
amount
vlpincorpor
g
protein
appear
similar
report
niv
virion
also
spite
fact
viral
protein
studi
reveal
use
rabbit
sera
rais
bacteri
express
hendra
viru
protein
howev
ratio
vlpincorpor
f
f
differ
virion
differ
like
reflect
time
protein
turnov
rather
reagent
use
reveal
sinc
previou
studi
puls
chase
experi
shown
similarli
vlpincorpor
f
f
intracellular
cleavag
precursor
niv
fusion
protein
cathepsin
l
result
near
equal
mix
matur
fusogen
precursor
form
absenc
nivspecif
band
two
differ
cell
lysat
prepar
process
similarli
shown
left
hand
panel
figur
confirm
specif
vlpincorpor
protein
immunoreact
vlp
surfac
glycoprotein
verifi
stain
purifi
unfix
vlp
immunogold
label
techniqu
use
nivspecif
mous
antiserum
nm
colloid
gold
particleconjug
goat
antimous
secondari
antibodi
jackson
immunoresearch
laboratori
inc
particl
view
em
neg
stain
use
unfix
particl
assur
surfaceexpos
antigen
would
reactiv
numer
vlp
gold
particl
decor
surfac
seen
figur
show
two
vlp
syncytium
format
classic
featur
niv
paramyxovirusinduc
cytopatholog
block
virusspecif
neutral
antibodi
similar
observ
made
cell
infect
niv
vlp
briefli
vlp
preincub
nivspecif
antibodi
junin
viru
jv
specif
antibodi
optimem
invitrogen
inc
medium
one
hour
inocul
onto
near
confluent
cell
monolay
grown
overnight
mm
dish
inoculum
remov
incub
hour
replac
optimem
plate
incub
overnight
overnight
monolay
view
format
syncytia
stain
crystal
violet
result
figur
show
cell
expos
niv
vlp
induc
syncytium
format
process
neutral
nivspecif
antibodi
prior
incub
unrel
jv
antibodi
fail
block
process
mice
group
five
inocul
subcutan
four
differ
concentr
purifi
vlp
boost
describ
method
neg
control
group
five
mice
inocul
steril
endotoxin
free
pb
inocul
mice
bled
submandibular
vein
day
primari
inocul
day
initi
evalu
sera
treatment
group
pool
ifa
method
use
determin
level
nivspecif
antibodi
result
figur
show
titer
reciproc
highest
serum
dilut
show
reactiv
increas
time
post
primari
inocul
ie
highest
titer
seen
day
titer
also
increas
vlp
dosag
although
day
three
higher
treatment
group
seem
produc
similar
titer
expect
mice
neg
control
group
remain
nonrespons
sera
test
individu
plaqu
reduct
neutral
method
doubl
dilut
sampl
figur
show
distinct
associ
vlp
dosag
abil
mount
neutral
antibodi
respons
mice
inocul
two
highest
vlp
dose
treatment
group
c
abl
induc
neutral
antibodi
day
sampl
mice
receiv
two
lower
concentr
vlp
ugdos
ugdos
correspond
treatment
group
b
respect
similarli
test
mice
respect
induc
neutral
antibodi
respons
titer
rang
expect
control
mice
induc
neutral
respons
niv
vlpinduc
activ
gene
involv
signal
innat
immun
respons
pcr
array
format
sabiosci
use
investig
modul
transcript
profil
gene
involv
innat
immun
respons
includ
tlr
signal
famili
member
downstream
signal
pathway
nfkb
irf
gene
repres
key
sensor
nonself
signal
ultim
shape
natur
innat
immun
respons
modul
type
durat
adapt
immun
respons
differenti
express
gene
vlpexpos
cell
rel
mock
infect
cell
measur
realtim
pcr
concentr
total
cell
rna
vlpstimul
mock
stimul
control
cell
use
first
strand
synthesi
sybr
green
pcr
amplif
relev
gene
describ
method
integr
rna
sampl
confirm
gel
electrophoresi
figur
data
repres
differenti
transcript
profil
vlp
expos
vs
mock
stimul
cell
shown
heat
map
figur
cutoff
threshold
use
determin
modul
gene
express
note
signific
vlpstimul
upregul
fold
fold
express
gene
respect
close
four
fold
fold
upregul
note
also
gene
target
gene
downstream
nfkb
pathway
irf
pathway
respect
use
minigenomebas
function
assay
establish
condit
describ
result
shown
figur
allow
us
produc
substanti
quantiti
niv
vlp
abl
undertak
studi
describ
manuscript
shown
particl
function
assembl
biolog
activ
abl
induc
innat
immun
respons
neutral
antibodi
respons
nativ
vlp
use
studi
variou
aspect
viru
lifecycl
carrier
deliv
heterolog
protein
vaccin
deliv
small
molecul
gene
therapi
purpos
particularli
importantli
use
highli
effect
vaccin
nativ
form
vaccin
niv
diseas
develop
far
would
safe
protect
human
two
vaccin
strategi
alreadi
explor
canari
poxbas
vector
approach
solubl
subunit
approach
niv
vaccin
former
method
undergo
develop
veterinari
vaccin
approach
evalu
human
use
vaccin
mainli
prevent
hiv
aid
subunit
approach
limit
alreadi
mention
one
particular
challeng
reveal
studi
test
solubl
niv
g
proteinbas
subunit
vaccin
formul
adjuv
potenti
difficulti
erad
infect
central
nervou
system
studi
live
viru
present
brain
one
cat
viral
rna
present
throughout
day
postchalleng
period
brain
remain
challeng
anim
recent
report
vaccin
strategi
requir
simultan
inocul
two
vsvdg
vector
one
express
niv
g
express
niv
f
protein
interest
note
supernat
cell
coinfect
two
defect
virus
infecti
could
passag
indefinit
absenc
vsv
g
transcomplement
vaccin
approach
seem
promis
sinc
selfpropag
stock
two
virus
induc
robust
neutral
antibodi
respons
mice
howev
potenti
pathogen
vsvbase
vaccin
vector
remain
concern
potenti
recombin
event
result
singl
vsv
vector
viru
express
niv
protein
unlik
may
still
problemat
human
use
vaccin
nativ
vlp
like
one
produc
allow
viral
protein
present
immun
system
conform
virion
effect
b
cell
respons
vlp
particularli
effect
produc
protect
antibodi
respons
viruslik
size
rang
particul
natur
viruslik
dens
repetit
order
surfac
structur
space
antigen
epitop
vlp
also
optim
b
cell
activ
em
analysi
show
particl
resembl
real
viru
term
size
surfac
structur
imag
figur
first
elucid
vlp
structur
paramyxoviru
imag
cryoem
provid
care
assess
morpholog
allud
surfac
similar
reveal
measl
viru
imag
techniqu
dr
elizabeth
wright
emori
univers
protein
vlp
surfac
clearli
visibl
averag
distanc
spike
nm
standard
deviat
nm
interest
given
epitop
space
nm
known
suffici
drive
optim
b
cell
activ
niv
f
g
n
proteincontain
vlp
consist
size
morpholog
parent
viru
also
report
previou
studi
evalu
proteinprotein
interact
facilit
vlp
format
howev
studi
particleincorpor
niv
f
protein
predominantli
uncleav
precursor
form
find
clearli
distinct
sinc
vlp
contain
substanti
amount
cleav
f
protein
may
relat
ratio
interact
protein
express
transfect
cell
recent
studi
ndv
vlp
particleincorpor
protein
report
viruslik
protein
ratio
f
protein
remain
precursor
form
cleavag
site
requir
produc
fusion
compet
form
mutat
design
effect
vlpincorpor
nonfusogen
f
protein
may
rel
fusogen
form
level
qualiti
vlpinduc
immun
respons
clear
present
sinc
differ
immunogen
fusioncompet
fusiondefect
vlp
experiment
evalu
far
howev
recent
report
suggest
viral
fusogen
membran
glycoprotein
may
enhanc
vaccin
potenc
immunogold
label
unfix
niv
vlp
confirm
surfac
protein
vlp
function
assembl
biolog
activ
figur
could
deduc
presenc
biolog
activ
g
f
protein
vlp
surfac
fact
abl
induc
format
syncytia
cell
figur
process
requir
interact
surfac
glycoprotein
attach
protein
g
fusion
compet
f
protein
come
contact
cognat
receptorbear
cell
format
syncytia
multinucl
cell
replic
compet
envelop
virus
especi
paramyxovirus
induc
process
describ
fusion
within
block
neutral
prior
treatment
viru
specif
antisera
contrast
fusion
without
induc
nonrepl
virus
high
multipl
infect
block
pretreat
virusspecif
antibodi
refer
therein
nonrepl
particl
likewis
induc
syncytia
format
cell
could
neutral
nivspecif
antibodi
figur
knowledg
first
studi
describ
fusion
without
induc
vlp
paramyxoviru
envelop
virus
although
describ
vlp
nonenvelop
rotaviru
mechan
fusion
without
clear
two
model
propos
one
propos
particl
connect
adjac
cell
effect
promot
fusion
particl
decor
surfac
glycoprotein
fuse
target
cell
membran
glycoprotein
complex
diffus
freeli
lipid
bilay
mimic
fusion
within
type
vlpinduc
syncytia
format
eventu
cell
death
also
known
process
investig
neutral
antibodi
respons
critic
correl
protect
mediat
prophylact
vaccin
nativ
vlp
promis
highli
effect
prophylact
vaccin
paramyxovirus
like
niv
other
like
ndv
measl
neutral
immun
respons
known
play
pivot
role
protect
diseas
vlp
highli
effect
immunogen
especi
three
higher
treatment
group
produc
high
level
respons
day
figur
importantli
niv
vlp
abl
induc
neutral
antibodi
respons
clearli
dosedepend
figur
ten
mice
receiv
primari
inocul
mg
vlp
subgroup
c
abl
produc
respons
even
anim
receiv
first
dose
ugmous
treatment
group
b
respect
produc
neutral
antibodi
neutral
antibodi
respons
first
seen
day
increas
titer
seen
anim
within
week
believ
respons
induc
nonrepl
potenti
safe
particl
formul
without
adjuv
compar
favor
level
respons
induc
equival
time
point
replic
compet
pseudotyp
virus
immunogen
nativ
vlp
report
previous
one
paramyxoviru
name
ndv
report
immun
respons
ndv
vlp
evalu
primari
inocul
mice
intraperiton
vlp
concentr
rang
mg
booster
dose
mg
without
adjuv
ndvspecif
titer
elisa
high
mous
treatment
group
neutral
antibodi
respons
mg
particl
also
detect
natur
innat
immun
respons
dictat
type
durat
adapt
immun
respons
mechan
niv
vlp
recogn
host
cell
trigger
induct
innat
immun
respons
translat
effect
adapt
immun
known
taken
first
step
figur
toward
understand
process
experiment
condit
describ
observ
vlpinduc
activ
gene
known
involv
induct
effect
innat
immun
respons
result
present
heat
map
figur
show
rel
mock
treat
cell
gene
nfkb
pathway
upregul
fold
result
vlp
exposur
irf
pathway
fold
higher
light
find
test
pcr
array
express
profil
set
gene
cell
earlier
later
time
point
identifi
upstream
effector
niv
vlprespons
signal
network
respect
murin
system
mani
avail
immunolog
reagent
knockout
strain
may
provid
best
system
identifi
host
sensor
current
minim
inform
live
niv
infectionrespons
cellsign
chang
none
arraybas
transcript
alter
compar
analysi
likewis
possibl
compar
niv
vlpinduc
transcript
modul
induc
paramyxoviru
vlp
sinc
knowledg
studi
undertaken
far
lastli
grow
number
report
point
viral
surfac
glycolprotein
relev
host
cell
signal
trigger
innat
immun
respons
believ
particl
like
niv
vlp
mani
viruslik
properti
includ
surfac
glycoprotein
organ
resembl
parent
viru
figur
would
induc
effect
innat
immun
respons
promot
desir
adapt
immun
final
describ
vlp
highli
effect
immunogen
abl
induc
neutral
antibodi
respons
anim
primari
inocul
littl
mg
vlp
protein
fusogen
properti
vlp
may
critic
relev
regard
light
recent
find
would
need
experiment
verifi
compar
potenc
fusioncompet
fusiondefect
vlp
vaccin
conclus
success
produc
substanti
quantiti
niv
vlp
need
character
niv
vlp
demonstr
mani
viruslik
properti
effect
immunogen
balbc
mice
find
basi
undertak
futur
challeng
studi
hamster
model
niv
diseas
